MAL15125049AZPrescription (MAL-A)

NATRIXAM 1.5mg/10mg, modified-release tablets

Generic Molecule: Amlodipine Besilate

ACTIVE & APPROVEDValid till: 24 Dec 2030
NPRA Official Regulatory Summary

NATRIXAM 1.5mg/10mg, modified-release tablets is a KKM-approved Prescription Medicine registered under MAL number MAL15125049AZ by SERVIER MALAYSIA SDN. BHD.. Its active ingredient is AMLODIPINE BESILATE 13.87mg, INDAPAMIDE 1.5mg, manufactured by LES LABORATOIRES SERVIER INDUSTRIE.

Holder (PRH)
SERVIER MALAYSIA SDN. BHD.
Manufacturer
LES LABORATOIRES SERVIER INDUSTRIE
First Registered
24 Dec 2025
Validity
24 Dec 2030

Prescription Required (Schedule Poison)

Need a valid doctor's prescription renewal in Malaysia?

Consult Online Doctor (Telehealth)

Active Ingredients & Strength Formulation

2 Components
Active Substance / MoleculeDeclared Strength / DosageGeneric Directory
AMLODIPINE BESILATE13.87mgFind Brands
INDAPAMIDE1.5mgFind Brands
Dosage values indicate declared active concentration per unit dose as registered with NPRA Malaysia.

Malaysian KKM Security Hologram Verification

FarmaChecker & Meditag™

By Malaysian Ministry of Health (KKM) regulation, all genuine registered pharmaceuticals, health supplements (MAL-N), and traditional products (MAL-T) distributed in Malaysia must feature an official tamper-evident security hologram sticker on the physical packaging.

1. Visual Tilt Check

Tilt the box under light to view the micro-engraved KKM coat of arms and multi-layer iridescent security patterns.

2. Match MAL Number

Ensure the printed MAL code matches MAL15125049AZ exactly on label and box.

3. FarmaChecker Scan

Scan using the official FarmaChecker app on iOS / Android to authenticate serial token with NPRA servers.

If the packaging lacks a security hologram or fails the FarmaChecker scan, do not consume and report to Cawangan Penguatkuasaan Farmasi (CPF KKM).
Frequently Asked Questions & Verification Details

Is NATRIXAM 1.5mg/10mg, modified-release tablets approved by KKM / NPRA?

Yes. NATRIXAM 1.5mg/10mg, modified-release tablets is actively registered with the National Pharmaceutical Regulatory Agency under official registration number MAL15125049AZ with current status PRODUCT APPROVED. Registration was filed by SERVIER MALAYSIA SDN. BHD..

What are the active ingredients of NATRIXAM 1.5mg/10mg, modified-release tablets?

The declared active therapeutic components are: AMLODIPINE BESILATE 13.87mg, INDAPAMIDE 1.5mg. Always follow dosage recommendations prescribed by a certified doctor or licensed pharmacist.

What are the registered generic alternatives in Malaysia?

In Malaysia, there are 26 registered brand formulations containing identical active ingredients (Amlodipine Besilate). You can review them in the alternative brands section above or consult your community pharmacist for generic bioequivalent substitution.

Semakan status pendaftaran KKM / NPRA: NATRIXAM 1.5mg/10mg, modified-release tablets (MAL15125049AZ) | Pengganti ubat di Malaysia | Bahan aktif ubat & maklumat farmasi.